v3.25.2
Segment Reporting - Segment Information about Reported Product Revenues, Depreciation and Amortization and Operating Income (Loss) (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Product Revenues        
Product revenues $ 375,090 $ 375,683 $ 728,944 $ 731,698
Significant Segment Expenses and Operating Performance        
Cost of sales 285,328 278,982 552,717 546,244
Net research and development expenses 22,558 21,861 46,774 44,606
Selling, general and administrative expenses 41,087 39,410 79,565 80,131
Restructuring expenses, net 2,108 2,442 6,622 9,680
Loss on sale of land and building, net     (2,196)  
Operating income (loss) 24,009 32,988 41,070 51,037
Other segment disclosures        
Depreciation and amortization 13,158 12,915 26,089 26,733
Operating Segments        
Product Revenues        
Product revenues 375,090 375,683 728,944 731,698
Corporate and Other Unallocated Expenses        
Significant Segment Expenses and Operating Performance        
Other operating expenses 24,526 23,456 47,694 48,134
Other segment disclosures        
Depreciation and amortization 511 229 985 756
Automotive Segments        
Product Revenues        
Product revenues 363,852 364,002 705,726 708,640
Automotive Segments | Operating Segments        
Product Revenues        
Product revenues 363,852 364,002 705,726 708,640
Significant Segment Expenses and Operating Performance        
Cost of sales 278,424 272,093 538,651 532,382
Net research and development expenses 17,818 17,012 37,202 34,436
Selling, general and administrative expenses 16,814 17,037 32,533 33,638
Restructuring expenses, net 1,924 1,694 6,438 8,808
Loss on sale of land and building, net     2,196  
Operating income (loss) 48,872 56,166 88,706 99,376
Other segment disclosures        
Depreciation and amortization 11,796 11,817 23,398 24,225
Medical Segments | Operating Segments        
Product Revenues        
Product revenues 11,238 11,681 23,218 23,058
Significant Segment Expenses and Operating Performance        
Cost of sales 5,729 6,101 12,005 12,014
Restructuring expenses, net 156   156 20
Other operating expenses 5,846 5,302 11,155 10,719
Impairment of intangible assets       530
Operating income (loss) (337) 278 58 (205)
Other segment disclosures        
Depreciation and amortization 851 869 1,706 1,752
Corporate Segments | Operating Segments        
Significant Segment Expenses and Operating Performance        
Restructuring expenses, net $ 28 $ 748 $ 28 $ 852